No two paths to the Arizona Fall League are the same. But it’s difficult to chart a more improbable one than what Harry Blum ...

Pfizer heads into Q3 earnings with strong drug sales and an attractive valuation, but declining COVID revenues and looming patent expirations pose challenges.

Diebold Nixdorf (NYSE: DBD), a global leader in transforming the way people bank and shop, today announced that its Board of Directors has authorized a new share repurchase program whereby the company ...

Looking at the summary results and graphs provided by the AI, one might simply believe, 'I see, if I make predictions based ...

After finishing an article and thinking, "Alright, it's done," there's still the task of pasting it into note.Inserting the ...

Department of Health and Human Services finalized a rule that cuts 14 of the 60 criteria every certified electronic health ...

McDonald’s reports Q3 results on November 4. It should peel back what’s been an eventful stretch for the chain staring down ...

A first-principles guide to AI Fraud Detection, including its operating chain, economics, authoritative records, failure ...

Viking Therapeutics VKTX is set to report third-quarter 2026 earnings on Oct. 28, after market close. Because the company has no marketed drugs in its portfolio, it is not expected to record revenue.

Deion Sanders’ Colorado is becoming a laughingstock. The Buffaloes blew a 24-20 lead against Oklahoma State, surrendering 37 unanswered points in a humiliating 57-24 defeat.

NASA will not make a decision on whether to use a SpaceX or Blue Origin moon lander until testing shows which one is the obvious choice.

The health of the community depends on such a holistic approach. Buffalo could stand some improvement on that note.